|Articles|March 1, 2018
- Pharmaceutical Executive-03-01-2018
- Volume 38
- Issue 3
Pharmaceutical Executive, March 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharma: Meet Your New Neighborsover 8 years ago
Risk Sharing, Italian Styleover 8 years ago
The Quest to Measure Upover 8 years ago
Full Disclosure Demanded for Pharma Industryover 8 years ago
Setting the Standard: William Soliman, ACMAover 8 years ago
The Law of Unintended Consequencesover 8 years ago
Pricing Turning Point: The Case for Innovating Pharma’s Modelover 8 years ago
Showdown Nears on Europe Research Incentivesover 8 years ago
The Personalized Genetic Profile: It’s Time to Alignover 8 years ago
Country Report: IndiaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
4
Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals
5